CD70 靶向 HIT-CAR T 细胞对乳腺癌患者来源异种移植瘤的控制
Control of breast cancer patient-derived xenografts by CD70-targeted HIT-CAR T cells.
CAR T细胞疗法已在几种肿瘤类型中显示出临床成功,但在乳腺癌中尚未实现,其晚期阶段仍无法治愈。
80.3分
★★★★☆
DISEASE HUB
FOR TREATMENT
按「中国试验优先 → 正在招募 → 更新更近」排序。信息来自 ClinicalTrials.gov 与 CDE 公开登记。能否入组、费用与可及性,以登记原文和主治医生判断为准。
FOR RESEARCH
Control of breast cancer patient-derived xenografts by CD70-targeted HIT-CAR T cells.
CAR T细胞疗法已在几种肿瘤类型中显示出临床成功,但在乳腺癌中尚未实现,其晚期阶段仍无法治愈。
MEMBER ACCOUNT
登录成功会直接打开下一页。